National Comprehensive Cancer Network



About NCCN

Ovarian Cancer Panel - Disclosures as of 7/20/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Ronald D. Alvarez, MD

None

Eli Lilly and Company;
GlaxoSmithKline;
Ortho Biotech Products, L.P.

None

None

None

Deborah K. Armstrong, MD

None

Abraxis Bioscience, Inc.;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Morphotek Inc.

None

None

None

Barry Boston, MD

None

Bayer HealthCare;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

None

Robert Burger, MD, FACOG, FACS

None

None

None

None

None

Lee-may Chen, MD

None

None

None

None

None

Larry Copeland, MD

None

Bayer HealthCare;
Celgene Corporation;
Eli Lilly and Company;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

Gynecologic Oncology Group

None

Marta Ann Crispens, MD

None

None

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

David M. Gershenson, MD

None

National Cancer Institute

None

Abbott Laboratories;
Amgen Inc.;
Eli Lilly and Company;
Johnson & Johnson;
Elsevier

None

Heidi J. Gray, MD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Perry W. Grigsby, MD, MS, MBA

None

None

None

None

None

Ardeshir Hakam, MD

None

None

None

None

None

Laura J. Havrilesky, MD

None

BD-TriPath Oncology;
Precision Therapeutics, Inc.

None

None

None

Miranda Hughes, PhD

None

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

Carolyn Johnston, MD

None

None

None

american cancer society-great lakes division;
michigan cancer consortium

None

Shashikant Lele, MD

None

None

None

None

None

Ursula A. Matulonis, MD

None

Eisai Inc.;
Merck & Co., Inc.

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Robert J. Morgan, MD, FACP

NIH-CTEP

None

None

Abbott Laboratories

None

David M. O'Malley, MD

None

KCI

None

None

None

Richard T. Penson, MD, MRCP

None

None

None

None

None

Steven W. Remmenga, MD

None

None

None

None

None

Paul Sabbatini, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Johnson & Johnson

None

None

None

Russell J. Schilder, MD

None

None

None

None

None

Julian C. Schink, MD

None

None

None

None

None

Nelson Teng, MD, PhD

None

None

None

None

None

Theresa L. Werner, MD

None

None

None

None

None